Sec Form 13D Filing - Saba Capital Management L.P. filing for TEMPLETON GLOBAL INCOME FUND (GIM) - 2021-05-12

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 7)*

Templeton Global Income Fund
(Name of Issuer)

Common Shares, No par value
(Title of Class of Securities)

880198106
(CUSIP Number)

Saba Capital Management, L.P.

405 Lexington Avenue

58th Floor

New York, NY 10174

Attention: Michael D'Angelo

(212) 542-4635

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

May 11, 2021
(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [X]

(Page 1 of 7 Pages)

______________________________

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




CUSIP No.  880198106 SCHEDULE 13D/A Page 2 of 7 Pages

1

NAME OF REPORTING PERSON

Saba Capital Management, L.P.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

3

SEC USE ONLY

4

SOURCE OF FUNDS

OO (see Item 3)

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

24,565,016

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

24,565,016

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

24,565,016

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

18.31%

14

TYPE OF REPORTING PERSON

PN; IA

The percentages used herein are calculated based upon 134,144,158 shares of common stock outstanding as of 2/05/21, as disclosed in the company's definitive proxy statement filed with the SEC on 3/09/2021.


CUSIP No.  880198106 SCHEDULE 13D/A Page 3 of 7 Pages

1

NAME OF REPORTING PERSON

Boaz R. Weinstein

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

3

SEC USE ONLY

4

SOURCE OF FUNDS

OO (see Item 3)

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

24,565,016

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

24,565,016

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

24,565,016

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

18.31%

14

TYPE OF REPORTING PERSON

IN

The percentages used herein are calculated based upon 134,144,158 shares of common stock outstanding as of 2/05/21, as disclosed in the company's definitive proxy statement filed with the SEC on 3/09/2021.


CUSIP No.  880198106 SCHEDULE 13D/A Page 4 of 7 Pages

1

NAME OF REPORTING PERSON

Saba Capital Management GP, LLC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

3

SEC USE ONLY

4

SOURCE OF FUNDS

OO (see Item 3)

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

24,565,016

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

24,565,016

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

24,565,016

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

18.31%

14

TYPE OF REPORTING PERSON

OO

The percentages used herein are calculated based upon 134,144,158 shares of common stock outstanding as of 2/05/21, as disclosed in the company's definitive proxy statement filed with the SEC on 3/09/2021.


CUSIP No.  880198106 SCHEDULE 13D/A Page 5 of 7 Pages

Item 1.

SECURITY AND ISSUER

 

 

 

This Amendment No. 7 amends and supplements the statement on Schedule 13D filed with the SEC on 11/18/20, as amended by Amendment No. 1 filed 12/9/20, Amendment No. 2 filed 12/16/20, Amendment No. 3 filed 12/28/20, Amendment No. 4 filed 12/29/20, Amendment No. 5 filed 1/14/21, and Amendment No. 6 filed 1/29/21; with respect to the common shares of Templeton Global Income Fund.  This Amendment No. 7 amends Items 3, 4,and 5, as set forth below.

 

 

Item 3.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

 

 

 

Item 3 of the Schedule 13D is hereby amended and restated as follows:

Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business.  In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time.  Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of approximately $134,243,537 was paid to acquire the Common Shares reported herein.


Item 4.

PURPOSE OF TRANSACTION

 

 

 

Item 4 of the Schedule 13D is hereby amended and supplemented as follows:

On May 11, 2021, the independent inspector for the Issuer's 2021 annual meeting of shareholders (the "Annual Meeting") certified that Saba Capital's nominees, Aditya Bindal, Frederic Gabriel, Paul Kazarian, and Pierre Weinstein (each of the foregoing, with the exception of Mr. Gabriel, a Saba Capital employee), have been elected to the Issuer's Board based on the shareholder votes cast at the Annual Meeting.


Item 5.

INTEREST IN SECURITIES OF THE ISSUER

 

 

(a)

Item 5 (a)-(c) of the Schedule 13D is hereby amended and restated as follows:

See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons.  The percentages used herein are calculated based upon 134,144,158 shares of common stock outstanding as of 2/05/21, as disclosed in the company's definitive proxy statement filed with the SEC on 3/09/2021.

 

 

(b)

See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

 

 


CUSIP No.  880198106 SCHEDULE 13D/A Page 6 of 7 Pages

(c)

The transactions in the Common Shares effected over the past sixty days by the Reporting Persons, if any, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date:  May 12, 2021

 

SABA CAPITAL MANAGEMENT, L.P.

 

By:  /s/ Michael D'Angelo

 

Name: Michael D'Angelo

Title: Chief Compliance Officer

 

 

 

 

 

SABA CAPITAL MANAGEMENT GP, LLC

 

By:  /s/ Michael D'Angelo

Name: Michael D'Angelo

Title: Authorized Signatory

 

 

 

 

 

BOAZ R. WEINSTEIN

 

By:  /s/ Michael D'Angelo

 

Name: Michael D'Angelo

 

Title: Attorney-in-fact*

 

* Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823

 

 

 



CUSIP No.  880198106 SCHEDULE 13D/A Page 7 of 7 Pages

Schedule A

This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker.

Trade Date Buy/Sell Shares Price

None